Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$31.23 - $40.91 $35,570 - $46,596
-1,139 Reduced 6.07%
17,624 $684,000
Q4 2023

Feb 13, 2024

SELL
$21.16 - $30.8 $5,480 - $7,977
-259 Reduced 1.36%
18,763 $577,000
Q3 2023

Nov 13, 2023

BUY
$21.23 - $24.28 $8,767 - $10,027
413 Added 2.22%
19,022 $425,000
Q2 2023

Aug 04, 2023

BUY
$21.06 - $24.0 $5,454 - $6,216
259 Added 1.41%
18,609 $399,000
Q1 2023

May 12, 2023

BUY
$23.0 - $29.88 $1,886 - $2,450
82 Added 0.45%
18,350 $440,000
Q4 2022

Feb 10, 2023

SELL
$16.14 - $23.55 $5,665 - $8,266
-351 Reduced 1.89%
18,268 $423,000
Q3 2022

Nov 14, 2022

BUY
$15.46 - $20.1 $3,308 - $4,301
214 Added 1.16%
18,619 $298,000
Q2 2022

Aug 12, 2022

SELL
$14.22 - $20.88 $19,552 - $28,710
-1,375 Reduced 6.95%
18,405 $326,000
Q1 2022

May 13, 2022

SELL
$17.2 - $22.5 $20,846 - $27,270
-1,212 Reduced 5.77%
19,780 $403,000
Q4 2021

Feb 11, 2022

SELL
$17.5 - $21.35 $19,705 - $24,040
-1,126 Reduced 5.09%
20,992 $392,000
Q3 2021

Nov 12, 2021

SELL
$17.75 - $25.39 $13,152 - $18,813
-741 Reduced 3.24%
22,118 $437,000
Q2 2021

Aug 13, 2021

SELL
$21.74 - $25.28 $804 - $935
-37 Reduced 0.16%
22,859 $540,000
Q1 2021

May 07, 2021

BUY
$19.25 - $26.1 $56,614 - $76,760
2,941 Added 14.74%
22,896 $543,000
Q4 2020

Feb 12, 2021

SELL
$17.83 - $22.29 $10,216 - $12,772
-573 Reduced 2.79%
19,955 $400,000
Q3 2020

Nov 04, 2020

SELL
$15.78 - $20.82 $7,353 - $9,702
-466 Reduced 2.22%
20,528 $427,000
Q2 2020

Aug 12, 2020

BUY
$15.49 - $23.51 $30,484 - $46,267
1,968 Added 10.34%
20,994 $367,000
Q1 2020

May 04, 2020

SELL
$13.89 - $25.45 $15,265 - $27,969
-1,099 Reduced 5.46%
19,026 $311,000
Q4 2019

Feb 05, 2020

SELL
$10.7 - $22.24 $1,818 - $3,780
-170 Reduced 0.84%
20,125 $414,000
Q3 2019

Nov 08, 2019

SELL
$10.16 - $13.28 $1,432 - $1,872
-141 Reduced 0.69%
20,295 $233,000
Q2 2019

Aug 13, 2019

BUY
$10.62 - $16.59 $18,298 - $28,584
1,723 Added 9.21%
20,436 $269,000
Q1 2019

May 06, 2019

SELL
$13.58 - $18.72 $8,243 - $11,363
-607 Reduced 3.14%
18,713 $283,000
Q4 2018

Feb 13, 2019

SELL
$14.78 - $19.68 $2,187 - $2,912
-148 Reduced 0.76%
19,320 $332,000
Q3 2018

Nov 09, 2018

BUY
$14.16 - $24.3 $4,956 - $8,505
350 Added 1.83%
19,468 $287,000
Q2 2018

Aug 08, 2018

BUY
$21.79 - $28.29 $67,570 - $87,727
3,101 Added 19.36%
19,118 $456,000
Q1 2018

May 07, 2018

SELL
$18.15 - $29.21 $15,645 - $25,179
-862 Reduced 5.11%
16,017 $409,000
Q4 2017

Feb 09, 2018

BUY
$9.3 - $19.14 $15,633 - $32,174
1,681 Added 11.06%
16,879 $312,000
Q3 2017

Nov 09, 2017

BUY
$9.15 - $11.97 $139,061 - $181,920
15,198
15,198 $159,000

Others Institutions Holding COLL

About COLLEGIUM PHARMACEUTICAL, INC


  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.31B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.